Annual Retained Earnings
-$65.42 M
-$10.52 M-19.15%
December 31, 2023
Summary
- As of February 8, 2025, ABVC annual retained earnings is -$65.42 million, with the most recent change of -$10.52 million (-19.15%) on December 31, 2023.
- During the last 3 years, ABVC annual retained earnings has fallen by -$39.78 million (-155.12%).
- ABVC annual retained earnings is now -281883.19% below its all-time high of -$23.20 thousand, reached on September 30, 2014.
Performance
ABVC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$70.55 M
-$186.60 K-0.27%
September 30, 2024
Summary
- As of February 8, 2025, ABVC quarterly retained earnings is -$70.55 million, with the most recent change of -$186.60 thousand (-0.27%) on September 30, 2024.
- Over the past year, ABVC quarterly retained earnings has dropped by -$8.24 million (-13.23%).
- ABVC quarterly retained earnings is now -304004.74% below its all-time high of -$23.20 thousand, reached on September 30, 2014.
Performance
ABVC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ABVC Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.1% | -13.2% |
| 3 y3 years | -155.1% | -130.9% |
| 5 y5 years | -229.1% | -130.9% |
ABVC Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.0% | at low | -83.3% | at low |
| 5 y | 5-year | -312.7% | at low | -345.1% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
ABVC BioPharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$70.55 M(+0.3%) |
| Jun 2024 | - | -$70.37 M(+1.5%) |
| Mar 2024 | - | -$69.35 M(+6.0%) |
| Dec 2023 | -$65.42 M(+19.2%) | -$65.42 M(+5.0%) |
| Sep 2023 | - | -$62.31 M(+5.6%) |
| Jun 2023 | - | -$58.99 M(+4.0%) |
| Mar 2023 | - | -$56.73 M(+3.3%) |
| Dec 2022 | -$54.90 M(+42.7%) | -$54.90 M(+9.7%) |
| Sep 2022 | - | -$50.04 M(+8.0%) |
| Jun 2022 | - | -$46.34 M(+4.2%) |
| Mar 2022 | - | -$44.48 M(+15.6%) |
| Dec 2021 | -$38.48 M(+50.1%) | -$38.48 M(+26.0%) |
| Sep 2021 | - | -$30.55 M(+6.3%) |
| Jun 2021 | - | -$28.74 M(+7.4%) |
| Mar 2021 | - | -$26.77 M(+4.4%) |
| Dec 2020 | -$25.64 M(+61.8%) | -$25.64 M(+23.3%) |
| Sep 2020 | - | -$20.79 M(+9.7%) |
| Jun 2020 | - | -$18.95 M(+10.8%) |
| Mar 2020 | - | -$17.10 M(+7.9%) |
| Dec 2019 | -$15.85 M(-20.3%) | -$15.85 M(+7.3%) |
| Sep 2019 | - | -$14.77 M(+9.0%) |
| Jun 2019 | - | -$13.56 M(+4.3%) |
| Mar 2019 | - | -$13.00 M(-34.6%) |
| Dec 2018 | -$19.88 M(+26.0%) | -$19.88 M(+20.0%) |
| Sep 2018 | - | -$16.57 M(+1.3%) |
| Jun 2018 | - | -$16.35 M(+2.0%) |
| Mar 2018 | - | -$16.04 M(+1.7%) |
| Dec 2017 | -$15.78 M(+2.5%) | -$15.78 M(+2.5%) |
| Sep 2017 | - | -$15.40 M(+29.9%) |
| Sep 2017 | -$15.40 M(+36.0%) | - |
| Jun 2017 | - | -$11.85 M(+1.1%) |
| Mar 2017 | - | -$11.72 M(+2.2%) |
| Dec 2016 | - | -$11.46 M(+1.2%) |
| Sep 2016 | -$11.32 M(+3487.9%) | -$11.32 M(+1592.1%) |
| Jun 2016 | - | -$669.20 K(+57.2%) |
| Mar 2016 | - | -$425.70 K(+823.4%) |
| Dec 2015 | - | -$46.10 K(-85.4%) |
| Sep 2015 | -$315.60 K(+1260.3%) | -$315.60 K(+1182.9%) |
| Jun 2015 | - | -$24.60 K(-5.0%) |
| Mar 2015 | - | -$25.90 K(+3.2%) |
| Dec 2014 | - | -$25.10 K(+8.2%) |
| Sep 2014 | -$23.20 K | -$23.20 K(-99.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | -$30.55 M(0.0%) |
| Mar 2014 | - | -$30.55 M(0.0%) |
| Dec 2013 | - | -$30.55 M(0.0%) |
| Sep 2013 | -$30.55 M(+0.8%) | -$30.55 M(0.0%) |
| Jun 2013 | - | -$30.55 M(+0.1%) |
| Mar 2013 | - | -$30.51 M(+0.1%) |
| Dec 2012 | - | -$30.47 M(+0.5%) |
| Sep 2012 | -$30.31 M(+5.4%) | -$30.31 M(+0.6%) |
| Jun 2012 | - | -$30.12 M(+1.2%) |
| Mar 2012 | - | -$29.77 M(+1.8%) |
| Dec 2011 | - | -$29.24 M(+1.6%) |
| Sep 2011 | -$28.77 M(+11.7%) | -$28.77 M(+2.4%) |
| Jun 2011 | - | -$28.09 M(+4.3%) |
| Mar 2011 | - | -$26.92 M(+2.7%) |
| Dec 2010 | - | -$26.22 M(+1.8%) |
| Sep 2010 | -$25.76 M(+13.6%) | -$25.76 M(+1.7%) |
| Jun 2010 | - | -$25.34 M(+1.0%) |
| Mar 2010 | - | -$25.09 M(+3.0%) |
| Dec 2009 | - | -$24.35 M(+7.3%) |
| Sep 2009 | -$22.69 M(+52.2%) | -$22.69 M(+7.8%) |
| Jun 2009 | - | -$21.04 M(+12.2%) |
| Mar 2009 | - | -$18.76 M(+6.0%) |
| Dec 2008 | - | -$17.69 M(+18.6%) |
| Sep 2008 | -$14.91 M(+152.4%) | -$14.91 M(+30.1%) |
| Jun 2008 | - | -$11.46 M(+24.8%) |
| Mar 2008 | - | -$9.18 M(+24.6%) |
| Dec 2007 | - | -$7.37 M(+5992.1%) |
| Sep 2007 | -$5.91 M(+5983.6%) | - |
| Jun 2007 | - | -$121.00 K(+11.6%) |
| Mar 2007 | - | -$108.40 K(+11.6%) |
| Dec 2006 | -$97.10 K(+35.4%) | -$97.10 K(+10.6%) |
| Sep 2006 | - | -$87.80 K(+1.2%) |
| Jun 2006 | - | -$86.80 K(+9.0%) |
| Mar 2006 | - | -$79.60 K(+11.0%) |
| Dec 2005 | -$71.70 K(+59.3%) | -$71.70 K(+12.0%) |
| Sep 2005 | - | -$64.00 K(+10.9%) |
| Jun 2005 | - | -$57.70 K(+7.1%) |
| Mar 2005 | - | -$53.90 K(+19.8%) |
| Dec 2004 | -$45.00 K(-5.3%) | -$45.00 K(+16.6%) |
| Sep 2004 | - | -$38.60 K(-35.1%) |
| Jun 2004 | - | -$59.50 K(+13.8%) |
| Mar 2004 | - | -$52.30 K |
| Dec 2003 | -$47.50 K | - |
FAQ
- What is ABVC BioPharma annual retained earnings?
- What is the all time high annual retained earnings for ABVC BioPharma?
- What is ABVC BioPharma annual retained earnings year-on-year change?
- What is ABVC BioPharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for ABVC BioPharma?
- What is ABVC BioPharma quarterly retained earnings year-on-year change?
What is ABVC BioPharma annual retained earnings?
The current annual retained earnings of ABVC is -$65.42 M
What is the all time high annual retained earnings for ABVC BioPharma?
ABVC BioPharma all-time high annual retained earnings is -$23.20 K
What is ABVC BioPharma annual retained earnings year-on-year change?
Over the past year, ABVC annual retained earnings has changed by -$10.52 M (-19.15%)
What is ABVC BioPharma quarterly retained earnings?
The current quarterly retained earnings of ABVC is -$70.55 M
What is the all time high quarterly retained earnings for ABVC BioPharma?
ABVC BioPharma all-time high quarterly retained earnings is -$23.20 K
What is ABVC BioPharma quarterly retained earnings year-on-year change?
Over the past year, ABVC quarterly retained earnings has changed by -$8.24 M (-13.23%)